Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Article in BMC Cancer (March 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma
Article in Medical Oncology (March 2024)
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma
Article in Turkish Journal of Surgery (March 2024)